NFE2L2 and intestinal disorder: Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2), a known factor that regulates ROS, is considered a promising therapeutic target for the treatment of various gastrointestinal disorders, and can prevent intestinal diseases by regulating antioxidant enzymes and proinflammatory cytokines to maintain redox homeostasis.